Austria Germany Norway covid-19 vaccine Austria Germany Norway

European regulators say AstraZeneca vaccine safe, but can't rule out rare events

Reading now: 599
www.cidrap.umn.edu

The European Medicines Agency (EMA) safety committee today released the conclusions of its preliminary probe of blood clotting reports in people who received the AstraZeneca-Oxford COVID-19 vaccine.

The committee said immunization benefits still outweigh the risks, but may be linked to extremely rare cases of clots linked to low blood platelets, especially in those younger than 55.The eagerly awaited findings come in the wake of vaccine program suspensions in nearly 20 countries, mostly in Europe.

Countries such as Austria, Norway, and Germany reported a small number of suspected side effects, prompting the pauses, ordered mainly as a precaution during the EMA's investigation.

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA